Patient-controlled Analgesia Pumps Market Outlook for (2023 to 2033)

The global Patient-controlled Analgesia Pumps Market is anticipated to register a CAGR of 5% during the forecast period. The global market valuation is US$ 447 million in 2023 and is expected to reach US$ 729.1 million by 2033.

The increasing prevalence of chronic diseases such as cardiovascular disease is increasing the demand for patient-controlled analgesia pumps. The growing number of cancer cases and performed surgeries are fueling the global market size. Healthcare professionals are increasing the demand for patient-controlled analgesia pumps to manage patients' post-operative pain.

The growing aging population, expanding healthcare infrastructure, and increasing chronic pain are significantly driving the global market. Rapidly growing advanced technologies are developing safe, efficient, and user-friendly devices to improve patient outcomes. Enhanced drug delivery systems integrated with electronic health records help to monitor patients' health.

The adoption of portable patient-controlled analgesia pumps for home healthcare is driving the global market trend. Patients prefer these devices with cost-effective solutions to reduce hospital costs. Healthcare manufacturers are promoting patients' health by developing standardized devices with stringent regulatory guidelines.

Increasing awareness through education campaign and training programs are ensuring patients about the benefits of patient-controlled analgesia devices. The key companies are partnering with pharmaceutical companies to increase the adoption of smart technologies to promote their advanced products.

Key Highlights

  • In 2021, in the United States, around 92.1 million people were affected with cardiovascular disease as compared to other chronic diseases.
  • Increasing cases of cancer in Germany is boosting the sales of patient-controlled analgesia.
  • The rising generic population and number of chronic patients are advancing China market.
Attributes Details
Patient-controlled Analgesia Pumps Market Size, 2023 US$ 447 million
Patient-controlled Analgesia Pumps Market Size, 2033 US$ 729.1 million
Value-based CAGR from 2023 to 2033 5%

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Performance and Future Growth Prospects in Patient-controlled Analgesia Pumps Market

The global Patient-controlled Analgesia Pumps Market grew at a significant rate between 2018 and 2022. The global market captured a valuation of US$ 421.9 million with a CAGR of 5.1% in 2022. Healthcare professionals are increasing the adoption of patient-controlled analgesia devices to deliver the required drugs at the right place.

Around 50% of patients are hospitalized due to chronic pain, and 30% suffer persistent pain due to cancer disease. Patients who are facing moderate or little pain are increasing the adoption of portable patient-controlled analgesia devices at home. The rapidly growing advanced technologies in the healthcare sector are improving patient outcomes.

Key companies are integrating smart devices to relieve chronic patients and satisfy their needs. The adoption of sophisticated, wireless, and user-friendly equipment is expanding the patient-controlled analgesia pumps market size. These companies are likely to achieve their goals by acquiring maximum revenue during the forecast period.

Comparative Analysis of Adjacent Markets

The section below provides a comparative analysis of three interrelated markets. It dissects the distinctive characteristics of each market, encompassing their respective CAGRs and expected market values by 2033 while also delving into the pivotal factors that exert influence on their growth trajectories.

Patient-controlled Analgesia Pumps Market:

Differentiating Aspects Patient-controlled Analgesia Pumps Market
CAGR (2023 to 2033) 5.0%
Projected Market Value in 2033 US$ 729.1 million
Growth Factors The increasing incidence of chronic disease and generic population.
Opportunities Growing smart technologies and collaboration with research institutions.
Key Trends The adoption of user-friendly and portable devices.

Infusion Pump Market:

Differentiating Aspects Infusion Pump Market
CAGR (2023 to 2033) 5.0%
Projected Market Value in 2033 US$ 7.64 billion
Growth Factors Rising surgical procedures and chronic disease population.
Opportunities The adoption of infusion therapies improving the healthcare sector.
Key Trends Growing awareness and rapidly advancing technologies and treatment procedures.

Next Generation Infusion Pump Market:

Differentiating Aspects Next Generation Infusion Pump Market
CAGR (2023 to 2033) 4.8%
Projected Market Value in 2033 US$ 8,917.43 million
Growth Factors Increasing diabetes patients, emergency cases, and rising demand for improved efficiency.
Opportunities The growing research and development activities and improving insurance policies.
Key Trends Increasing trends of intravenous therapy and wearable infusion pumps.
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Country-wise Insights

Countries Share (2023 to 2033)
United States 32.6%
Japan 4.3%
Germany 7.1%
Countries CAGR (2023 to 2033)
Australia 5.6%
China 5.1%
India 5.3%
United Kingdom 4.5%

Chronic Patients Upsurge in the United States Market

The United States is estimated to capture a share of 32.6% of the global market by 2033. The growing numbers of generic patients, diabetes patients, and advanced healthcare settings are fueling the United States patient-controlled analgesia pumps market. The United States is likely to dominate the global market due to the higher rate of chronic disorders in the country.

In 2019, the most common deadly disease in the United States was kidney disease. Around 80 million people suffer from kidney disease in the country. Healthcare professionals are adopting patient-controlled analgesia devices during patients' surgical processes to minimize pain.

Increasing Cancer Cases Drive Germany Market

Germany contributes a significant share of 7.1% in the global market during the forecast period. The increasing number of cancer cases, rising disposable income, and diabetes patients are expanding Germany's patient-controlled analgesia pumps market.

Key companies are developing advanced technical healthcare devices to enhance patient outcomes. They are offering flexible, cost-effective, portable, and improved devices to satisfy end users' demand; according to a report by the WHO, around 628,519 new cases of cancer disease found in Germany in 2020. These incidences are uplifting the demand for patient-controlled analgesia pumps in the country.

Advanced Healthcare Infrastructure Fuel China Market

China is one of the significant countries that secured a CAGR of 5.1% in the global market during the forecast period. The increasing old age population, advanced healthcare technologies, and essential key players are expanding the China patient-controlled Analgesia pumps market.

In 2019, according to the WHO report, 176 million people suffered from chronic diseases. The increasing generic population is raising the demand for patient-controlled analgesia pumps. The growing pharmaceuticals, healthcare services, and medical devices are contributing significant role in the country.

The integration of artificial intelligence and the Internet of Things in healthcare devices by essential key manufacturers is surging the China market. These manufacturers are regulating stringent regulations to offer high-quality products.

Growing Innovation and Aging Population Drive Japan Market

Japan is estimated to capture a share of 4.3% in the global market during the forecast period. Emerging economies, a high standard of living, and growing technologies are fueling the Japan market. On the other hand, the increasing population of the aging demographic is surging the demand for patient-controlled analgesia pumps.

Patients prefer high-quality, better service, and cost-effective solutions to improve their health conditions. Japan is a hub of innovation and technology. Healthcare providers adopting cutting-edge technologies such as robotics, automation, and electronics are driving the Japan market.

Japanese companies are adopting several strategies to build trustworthy relationships with their clients. The distribution channels play a crucial role in expanding global reach and finding relevant end users. They understand the needs of products and services across various end-use industries and are advancing Japan's market share.

Skilled Healthcare Professionals Stimulate Demand for Analgesia Pumps in India

India is estimated to secure a CAGR of 5.3% in the global market by 2033. The rising medical tourism enhanced medical treatment, and high-quality services are fueling India's patient-controlled analgesia pumps market. The government initiated several programs to offer healthcare services at lower costs. The highly skilled workforce is largely enhancing patients' healthcare with essential healthcare devices.

The rising pharmaceutical sector, innovations in drug therapies, and smart machine technologies are playing crucial roles in hospitals. Manufacturers are offering smart devices at affordable prices are fulfill end users' requirements. The rising urbanization, industrialization, and preferring patients' choice of treatment are advancing the Indian market.

Category-wise Insights

PCA Pumps are Highly Sought-after in the Global Market

Category PCA Pumps
Share 75.5%

Based on product type, PCA pumps are estimated to capture a share of 75.5% during the forecast period. The demand for PCA pumps is widely increasing among hospitals to manage patients' pain after medical conditions and surgeries. These patient-managed pain relief pumps offer effective and flexible methods to relieve pain.

PCA pumps reduce the workload of service staff by providing self-administered medication. These pain relief pumps play a crucial role in patient care. PCA pumps are managing cancer pain with feature-rich devices and advanced medical devices. These factors are estimated to dominate the PCA pumps in the global market by 2033. On the other hand, pump accessories are also significantly fueling the global market by registering a better share of the market.

Chemo Therapy/ Oncology Upsurge the Global Market

Category Chemo therapy/ oncology
Share 36.6%

Based on application, the chemotherapy/oncology segment is likely to dominate the global market by capturing a share of 36.6% by 2033. The growing incidence of cancer is increasing the demand for chemotherapy/ oncology services to treat patients. The aging population suffers more prevalence of chronic disease, increasing the adoption of chemotherapy/ oncology services.

The growing technological advancements in diagnostic and cancer research institutions are improving chemotherapy to treat patients. The innovation of new drug therapies and other oncology therapies is advancing the global market revenue.

The growing awareness of early detection of cancer, awareness programs, and standardized treatment are increasing the demand for chemotherapy/ oncology. Pharmaceutical sectors are investing hugely in research and development activities.

The Hospital Sector dominates the Global Market

Category Hospital
Share 56.9%

Based on end-users, the hospital segment is likely to dominate the global market by registering a share of 56.9% by 2033. Rising diverse patients are increasing the demand for better healthcare services and products. Hospitals provide various healthcare specialists to treat patients' diseases, from medicine to surgical procedures.

The broad variety of services, advanced medical equipment, and suppliers are surging the global market size. Hospitals offer outpatient and inpatient services with the adoption of medical devices.

Hospitals offer excellent teaching facilities to enhance patient outcomes with their expertise. The government initiative plans a broader hospital sector to manage emergency medical care. It provides rehabilitation services for its patients.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape in the Patient-controlled Analgesia Pumps Market

Key players are playing a crucial role in highlighting global market revenue upward. They analyze and research on market and come out with unique and advanced ideas to develop improved products. These key players are adopting various marketing methodologies such as mergers, collaborations, acquisitions, product launches, and partnerships.

Key market players are improving patients' health with their highly equipped healthcare devices. They are supporting their customers with their standardized products. These key players make their efforts to provide suitable devices and take feedback from their relevant consumers. They are changing their products according to end users' preferences with easy-to-use machines.

Key Players in the Patient-controlled Analgesia Pumps Market

  • Smiths Group plc.
  • Fresenius Kabi Group,
  • Hospira (Pfizer Inc.),
  • Micrel Medical Devices,
  • Ace Medical Co. Ltd.
  • Terumo Corporation,
  • B.Braun Melsungen AG
  • Baxter International
  • Becton Dickinson and Company.
  • BD
  • ICU Medical

Recent Developments in the Patient-controlled Analgesia Pumps Market

  • In 2022, Smiths Medical announced its partnership with Bainbridge Health. This partnership took place to enhance the portfolio in medication safety.
  • In 2022, BD announced its agreement with Parata Systems with an amount of US$ 1.525 billion.
  • In 2022, the United States FDA announced its approval of Baxten’s infusion pump Novum IQ syringe. This device improves post-surgery pain management.
  • In 2022, Shanghai MicroPort Lifesciences Co. Ltd announced its approval of AutoEx Chemotherapy Infusion pumps.

Key Segments in the Patient-controlled Analgesia Pumps Market

By Product:

  • PCA Pumps
  • Pump Accessories

By Application:

  • Chemo Therapy/Oncology
  • Pediatrics/Neonatology
  • Gastroenterology
  • Hematology

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Home care settings

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How Big is the Patient-controlled Analgesia Pumps Market?

The patient-controlled analgesia pumps market valuation is US$ 729.1 million in 2023.

Which is the Biggest Market for Patient-controlled Analgesia Pumps?

The United States is the biggest market for patient-controlled analgesia pumps.

What is the Patient-controlled Analgesia Pumps Market CAGR in 2023?

The patient-controlled analgesia pumps market is likely to capture a CAGR of 5% in 2023.

What is the Current Market Trend?

The growing focus on portable patient-controlled analgesia devices.

Who are the Key Players in the Patient-controlled Analgesia Pumps Market?

ICU Medical, Ace Medical Co. Ltd., and Baxter International are the key players in the patient-controlled analgesia market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. PCA Pumps

        5.3.2. Pump Accessories

    5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Chemo Therapy/Oncology

        6.3.2. Pediatrics/Neonatology

        6.3.3. Gastroenterology

        6.3.4. Hematology

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033

        7.3.1. Hospitals

        7.3.2. Ambulatory Surgical Centers

        7.3.3. Home care settings

    7.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    8.1. Introduction

    8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. South Asia and Pacific

        8.3.6. East Asia

        8.3.7. Middle East and Africa

    8.4. Market Attractiveness Analysis By Region

9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. USA

            9.2.1.2. Canada

        9.2.2. By Product

        9.2.3. By Application

        9.2.4. By End-User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By Application

        9.3.4. By End-User

    9.4. Key Takeaways

10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Brazil

            10.2.1.2. Mexico

            10.2.1.3. Rest of Latin America

        10.2.2. By Product

        10.2.3. By Application

        10.2.4. By End-User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By Application

        10.3.4. By End-User

    10.4. Key Takeaways

11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Germany

            11.2.1.2. UK

            11.2.1.3. France

            11.2.1.4. Spain

            11.2.1.5. Italy

            11.2.1.6. Rest of Western Europe

        11.2.2. By Product

        11.2.3. By Application

        11.2.4. By End-User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By Application

        11.3.4. By End-User

    11.4. Key Takeaways

12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Poland

            12.2.1.2. Russia

            12.2.1.3. Czech Republic

            12.2.1.4. Romania

            12.2.1.5. Rest of Eastern Europe

        12.2.2. By Product

        12.2.3. By Application

        12.2.4. By End-User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By Application

        12.3.4. By End-User

    12.4. Key Takeaways

13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Bangladesh

            13.2.1.3. Australia

            13.2.1.4. New Zealand

            13.2.1.5. Rest of South Asia and Pacific

        13.2.2. By Product

        13.2.3. By Application

        13.2.4. By End-User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By Application

        13.3.4. By End-User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Product

        14.2.3. By Application

        14.2.4. By End-User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By Application

        14.3.4. By End-User

    14.4. Key Takeaways

15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. GCC Countries

            15.2.1.2. South Africa

            15.2.1.3. Israel

            15.2.1.4. Rest of MEA

        15.2.2. By Product

        15.2.3. By Application

        15.2.4. By End-User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Product

        15.3.3. By Application

        15.3.4. By End-User

    15.4. Key Takeaways

16. Key Countries Market Analysis

    16.1. USA

        16.1.1. Pricing Analysis

        16.1.2. Market Share Analysis, 2022

            16.1.2.1. By Product

            16.1.2.2. By Application

            16.1.2.3. By End-User

    16.2. Canada

        16.2.1. Pricing Analysis

        16.2.2. Market Share Analysis, 2022

            16.2.2.1. By Product

            16.2.2.2. By Application

            16.2.2.3. By End-User

    16.3. Brazil

        16.3.1. Pricing Analysis

        16.3.2. Market Share Analysis, 2022

            16.3.2.1. By Product

            16.3.2.2. By Application

            16.3.2.3. By End-User

    16.4. Mexico

        16.4.1. Pricing Analysis

        16.4.2. Market Share Analysis, 2022

            16.4.2.1. By Product

            16.4.2.2. By Application

            16.4.2.3. By End-User

    16.5. Germany

        16.5.1. Pricing Analysis

        16.5.2. Market Share Analysis, 2022

            16.5.2.1. By Product

            16.5.2.2. By Application

            16.5.2.3. By End-User

    16.6. UK

        16.6.1. Pricing Analysis

        16.6.2. Market Share Analysis, 2022

            16.6.2.1. By Product

            16.6.2.2. By Application

            16.6.2.3. By End-User

    16.7. France

        16.7.1. Pricing Analysis

        16.7.2. Market Share Analysis, 2022

            16.7.2.1. By Product

            16.7.2.2. By Application

            16.7.2.3. By End-User

    16.8. Spain

        16.8.1. Pricing Analysis

        16.8.2. Market Share Analysis, 2022

            16.8.2.1. By Product

            16.8.2.2. By Application

            16.8.2.3. By End-User

    16.9. Italy

        16.9.1. Pricing Analysis

        16.9.2. Market Share Analysis, 2022

            16.9.2.1. By Product

            16.9.2.2. By Application

            16.9.2.3. By End-User

    16.10. Poland

        16.10.1. Pricing Analysis

        16.10.2. Market Share Analysis, 2022

            16.10.2.1. By Product

            16.10.2.2. By Application

            16.10.2.3. By End-User

    16.11. Russia

        16.11.1. Pricing Analysis

        16.11.2. Market Share Analysis, 2022

            16.11.2.1. By Product

            16.11.2.2. By Application

            16.11.2.3. By End-User

    16.12. Czech Republic

        16.12.1. Pricing Analysis

        16.12.2. Market Share Analysis, 2022

            16.12.2.1. By Product

            16.12.2.2. By Application

            16.12.2.3. By End-User

    16.13. Romania

        16.13.1. Pricing Analysis

        16.13.2. Market Share Analysis, 2022

            16.13.2.1. By Product

            16.13.2.2. By Application

            16.13.2.3. By End-User

    16.14. India

        16.14.1. Pricing Analysis

        16.14.2. Market Share Analysis, 2022

            16.14.2.1. By Product

            16.14.2.2. By Application

            16.14.2.3. By End-User

    16.15. Bangladesh

        16.15.1. Pricing Analysis

        16.15.2. Market Share Analysis, 2022

            16.15.2.1. By Product

            16.15.2.2. By Application

            16.15.2.3. By End-User

    16.16. Australia

        16.16.1. Pricing Analysis

        16.16.2. Market Share Analysis, 2022

            16.16.2.1. By Product

            16.16.2.2. By Application

            16.16.2.3. By End-User

    16.17. New Zealand

        16.17.1. Pricing Analysis

        16.17.2. Market Share Analysis, 2022

            16.17.2.1. By Product

            16.17.2.2. By Application

            16.17.2.3. By End-User

    16.18. China

        16.18.1. Pricing Analysis

        16.18.2. Market Share Analysis, 2022

            16.18.2.1. By Product

            16.18.2.2. By Application

            16.18.2.3. By End-User

    16.19. Japan

        16.19.1. Pricing Analysis

        16.19.2. Market Share Analysis, 2022

            16.19.2.1. By Product

            16.19.2.2. By Application

            16.19.2.3. By End-User

    16.20. South Korea

        16.20.1. Pricing Analysis

        16.20.2. Market Share Analysis, 2022

            16.20.2.1. By Product

            16.20.2.2. By Application

            16.20.2.3. By End-User

    16.21. GCC Countries

        16.21.1. Pricing Analysis

        16.21.2. Market Share Analysis, 2022

            16.21.2.1. By Product

            16.21.2.2. By Application

            16.21.2.3. By End-User

    16.22. South Africa

        16.22.1. Pricing Analysis

        16.22.2. Market Share Analysis, 2022

            16.22.2.1. By Product

            16.22.2.2. By Application

            16.22.2.3. By End-User

    16.23. Israel

        16.23.1. Pricing Analysis

        16.23.2. Market Share Analysis, 2022

            16.23.2.1. By Product

            16.23.2.2. By Application

            16.23.2.3. By End-User

17. Market Structure Analysis

    17.1. Competition Dashboard

    17.2. Competition Benchmarking

    17.3. Market Share Analysis of Top Players

        17.3.1. By Regional

        17.3.2. By Product

        17.3.3. By Application

        17.3.4. By End-User

18. Competition Analysis

    18.1. Competition Deep Dive

        18.1.1. Smiths Group plc.

            18.1.1.1. Overview

            18.1.1.2. Product Portfolio

            18.1.1.3. Profitability by Market Segments

            18.1.1.4. Sales Footprint

            18.1.1.5. Strategy Overview

                18.1.1.5.1. Marketing Strategy

                18.1.1.5.2. Product Strategy

                18.1.1.5.3. Channel Strategy

        18.1.2. Fresenius Kabi Group,

            18.1.2.1. Overview

            18.1.2.2. Product Portfolio

            18.1.2.3. Profitability by Market Segments

            18.1.2.4. Sales Footprint

            18.1.2.5. Strategy Overview

                18.1.2.5.1. Marketing Strategy

                18.1.2.5.2. Product Strategy

                18.1.2.5.3. Channel Strategy

        18.1.3. Hospira (Pfizer Inc.),

            18.1.3.1. Overview

            18.1.3.2. Product Portfolio

            18.1.3.3. Profitability by Market Segments

            18.1.3.4. Sales Footprint

            18.1.3.5. Strategy Overview

                18.1.3.5.1. Marketing Strategy

                18.1.3.5.2. Product Strategy

                18.1.3.5.3. Channel Strategy

        18.1.4. Micrel Medical Devices,

            18.1.4.1. Overview

            18.1.4.2. Product Portfolio

            18.1.4.3. Profitability by Market Segments

            18.1.4.4. Sales Footprint

            18.1.4.5. Strategy Overview

                18.1.4.5.1. Marketing Strategy

                18.1.4.5.2. Product Strategy

                18.1.4.5.3. Channel Strategy

        18.1.5. Ace Medical Co. Ltd.

            18.1.5.1. Overview

            18.1.5.2. Product Portfolio

            18.1.5.3. Profitability by Market Segments

            18.1.5.4. Sales Footprint

            18.1.5.5. Strategy Overview

                18.1.5.5.1. Marketing Strategy

                18.1.5.5.2. Product Strategy

                18.1.5.5.3. Channel Strategy

        18.1.6. Terumo Corporation,

            18.1.6.1. Overview

            18.1.6.2. Product Portfolio

            18.1.6.3. Profitability by Market Segments

            18.1.6.4. Sales Footprint

            18.1.6.5. Strategy Overview

                18.1.6.5.1. Marketing Strategy

                18.1.6.5.2. Product Strategy

                18.1.6.5.3. Channel Strategy

        18.1.7. B.Braun Melsungen AG

            18.1.7.1. Overview

            18.1.7.2. Product Portfolio

            18.1.7.3. Profitability by Market Segments

            18.1.7.4. Sales Footprint

            18.1.7.5. Strategy Overview

                18.1.7.5.1. Marketing Strategy

                18.1.7.5.2. Product Strategy

                18.1.7.5.3. Channel Strategy

        18.1.8. Baxter International

            18.1.8.1. Overview

            18.1.8.2. Product Portfolio

            18.1.8.3. Profitability by Market Segments

            18.1.8.4. Sales Footprint

            18.1.8.5. Strategy Overview

                18.1.8.5.1. Marketing Strategy

                18.1.8.5.2. Product Strategy

                18.1.8.5.3. Channel Strategy

        18.1.9. Becton Dickinson and Company.

            18.1.9.1. Overview

            18.1.9.2. Product Portfolio

            18.1.9.3. Profitability by Market Segments

            18.1.9.4. Sales Footprint

            18.1.9.5. Strategy Overview

                18.1.9.5.1. Marketing Strategy

                18.1.9.5.2. Product Strategy

                18.1.9.5.3. Channel Strategy

        18.1.10. BD

            18.1.10.1. Overview

            18.1.10.2. Product Portfolio

            18.1.10.3. Profitability by Market Segments

            18.1.10.4. Sales Footprint

            18.1.10.5. Strategy Overview

                18.1.10.5.1. Marketing Strategy

                18.1.10.5.2. Product Strategy

                18.1.10.5.3. Channel Strategy

        18.1.11. ICU Medical

            18.1.11.1. Overview

            18.1.11.2. Product Portfolio

            18.1.11.3. Profitability by Market Segments

            18.1.11.4. Sales Footprint

            18.1.11.5. Strategy Overview

                18.1.11.5.1. Marketing Strategy

                18.1.11.5.2. Product Strategy

                18.1.11.5.3. Channel Strategy

19. Assumptions & Acronyms Used

20. Research Methodology

Recommendations

Healthcare

Patient Portal Market

November 2016

REP-GB-2069

July 2024

345 pages

Healthcare

Patient Handling Equipment Market

January 2016

REP-GB-1201

June 2024

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Patient-Controlled Analgesia Pumps Market